• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

JAMA Viewpoint: Emerging Zika pandemic requires more WHO action now

Bioengineer.org by Bioengineer.org
January 28, 2018
in Headlines, Health, Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

IMAGE: Daniel Lucey, M.D., M.P.H., is Senior Scholar at the O'Neill Institute for National and Global Health Law.

Credit: Georgetown University

WASHINGTON – The World Health Organization's Director-General should convene "urgently" a meeting of International Health Regulations' Emergency Committee to advise on the emerging Zika pandemic and galvanize global action, say two Georgetown University professors.

In their JAMA Viewpoint published online Jan. 27, Daniel Lucey, MD, MPH, and Lawrence O. Gostin, JD, of the O'Neill Institute for National and Global Health Law at Georgetown, explain that the WHO's failure to act decisively early on in the Ebola crises likely cost thousands of lives, and they warn of potentially serious ramifications if more action isn't taken immediately with Zika.

Until recently, the Zika virus was regarded as a mild disease, but the emergence of a possible link to Guillain-Barré syndrome and neurologic birth defects (microcephaly), seen in some affected countries, has elevated concern. Recent modeling of the disease's spread "anticipates significant international spread by travelers from Brazil to the rest of the Americas, Europe, and Asia," Lucey and Gostin write.

"The critical lesson learned from the WHO's handling of the Ebola crises was the need for early and decisive action," says Gostin. "Yet WHO, and even advanced countries like the United States, were caught off guard. It would be unconscionable if a lack of preparedness resulted in hundreds of unnecessary cases of Zika and potential congenital abnormalities in newborns."

Lucey and Gostin write, "An Emergency Committee should be convened urgently to advise the Director-General about the conditions necessary to declare a Public Health Emergency of International Concern (PHEIC).The very process of convening the committee would catalyze international attention, funding, and research. While Brazil, [the Pan American Health Organization], and the [Centers for Disease Control and Prevention] have acted rapidly, WHO headquarters has thus far not been sufficiently proactive given potentially serious ramifications."

Convening the committee "does not mean that the Director-General should declare a PHEIC," and they point to the example of MERS where the WHO Emergency Committee met 10 times yet advised against declaring a PHEIC, while still offering guidance to Member states.

Additional recommendations outlined by Lucey and Gostin include mosquito control (removing water sources where breeding occurs, use of insecticide, etc.), health information campaigns, country-issued travel advisories, accelerated research and development of vaccines and declarations of public health.

"The international community cannot afford to wait for WHO to act," they conclude.

Lucey, is an infectious disease specialist and a Senior Scholar at the O'Neill Institute, and adjunct professor of medicine at Georgetown University School of Medicine.

Gostin is faculty director of the O'Neill Institute. He served on the National Academy of Medicine's Commission on a Global Health Risk Framework for the Future whose report earlier this month warned of health system deficiencies specifically in managing a pandemic disease crisis.

###

Click here for a list of Georgetown subject matter experts who can provide comment and context on Zika in the areas of infectious disease (clinical and molecular biology), biology, global health, maternal health and Guillain-Barré syndrome.

The O'Neill Institute for National and Global Health Law at Georgetown University is the premier center for health law, scholarship, and policy. Its mission is to contribute to a more powerful and deeper understanding of the multiple ways in which law can be used to improve the public's health, using objective evidence as a measure. The O'Neill Institute seeks to advance scholarship, science, research, and teaching that will encourage key decision-makers in the public, private, and civil society to employ the law as a positive tool for enabling more people in the United States and throughout the world to lead healthier lives.

Media Contact

Karen Teber
[email protected]

http://www.law.georgetown.edu/oneillinstitute/inde

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Food Insecurity and Diabetes: Pathways to Glycemic Control

August 25, 2025
blank

Scoping Review: Delirium Detection Tools in Long-Term Care

August 25, 2025

Surviving Deserts: The Adaptive Genus Tribulus

August 25, 2025

Direct Repeats Discovered Near Intron Splice Sites

August 25, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    135 shares
    Share 54 Tweet 34
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Food Insecurity and Diabetes: Pathways to Glycemic Control

Scoping Review: Delirium Detection Tools in Long-Term Care

Surviving Deserts: The Adaptive Genus Tribulus

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.